Docetaxel

Form: injection

Strength: 20 mg/1 mL, 80 mg/4 mL,160 mg/8 mL

Reference Brands: Taxotere®.

Category: Oncology Cancer Care

Docetaxel is an intravenous chemotherapy agent used to treat a variety of cancers, including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, and head and neck cancers. As a taxane, it works by inhibiting cell division, effectively preventing cancer cell proliferation. Available in 20 mg/mL, 80 mg/4 mL, and 160 mg/8 mL vial strengths, Docetaxel is marketed under the brand name Taxotere® in both the US and EU. The drug offers significant B2B opportunities for pharmaceutical companies targeting oncology treatments in these regions.